Protamine sulfate: Crouching clot or hidden hemorrhage?

Anesthesia and Analgesia

Volumn 111, Issue 3, 2010, Pages 593-594

  Nielsen, Vance G ^a   Nini Malayaman, S ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; HEPARIN; PROTAMINE SULFATE; THROMBIN; THROMBOPLASTIN; ANTICOAGULANT AGENT; HEPARIN ANTAGONIST; PROTAMINE;

ANTICOAGULATION; BLEEDING; DRUG MECHANISM; EDITORIAL; HUMAN; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; DRUG ANTAGONISM; DRUG EFFECT; HEMOSTASIS; METABOLISM; NOTE;

ANTICOAGULANTS; BLOOD LOSS, SURGICAL; FACTOR VII; HEMOSTASIS; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; PROTAMINES; RISK FACTORS;

EID: 77956409914     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181eb6388     Document Type: Editorial

References (14)

1. Gravlee GP, Haddon WS, Rothberger HK, Mills SA, Rogers AT, Bean VE, Buss DH, Prough DS, Cordell AR. Heparin dosing and monitoring for cardiopulmonary bypass: a comparison of techniques with measurement of subclinical plasma coagulation. J Thorac Cardiovasc Surg 1990;99:518-27
2. Cobel-Geard RJ, Hassouna HI. Interaction of protamine sulfate with thrombin. Am J Hematol 1983;14:227-33
3. Chu AJ, Wang Z, Raicu M, Beydoun S, Ramos N. Protamine inhibits tissue factor-initiated extrinsic coagulation. Br J Haematol 2001;115:392-9 (Pubitemid 34203508)
4. Nielsen VG. Protamine enhances fibrinolysis by decreasing clot strength: role of tissue factor-initiated thrombin generation. Ann Thorac Surg 2006;81:1720-7
5. Ni Ainle F, Preston RJS, Jenkins PV, Nel HJ, Johnson JA, Smith OP, White B, Fallon PG, O'Donnell JS. Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation. Blood 2009;114:1658-65
6. Barstad RM, Stephens RW, Hamers MJ, Sakariassen KS. Protamine sulfate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity. Thromb Haemost 2000;83:334-7
7. Kresowik TF, Wakefield TW, Fessler RD II, Stanley JC. Anticoagulant effects of protamine sulfate in a canine model. J Surg Res 1988;45:8-14
8. Eslin DE, Zhang C, Samuels KJ, Rauova L, Zhai L, Niewiarowski S, Cines DB, Poncz M, Kowalska MA. Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. Blood 2004;104:3173-80
9. Levy JH, Tanaka KA. Anticoagulation and reversal paradigms: is too much of a good thing bad? Anesth Analg 2009;108:692-4
10. Bolliger D, Szlam F, Azran M, Koyama K, Levy JH, Molinaro RJ, Tanaka KA. The anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations. Anesth Analg 2010;111:601-8
11. Butterworth J, Lin YA, Prielipp R, Bennett J, James R. The pharmacokinetics and cardiovascular effects of a single intravenous dose of protamine in normal volunteers. Anesth Analg 2002;94:514-22
12. Butterworth J, Lin YA, Prielipp RC, Bennett J, Hammon JW, James RL. Rapid disappearance of protamine in adults undergoing cardiac operation with cardiopulmonary bypass. Ann Thorac Surg 2002;74:1589-95
13. Nielsen VG, Audu P, Cankovic L, Lyerly RT III, Steenwyk BL, Armstead V, Powell G. Qualitative thrombelastographic detection of tissue factor in human plasma. Anesth Analg 2007; 104:59-64
14. Nielsen VG, Cohen BM, Cohen E. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via Thrombelastography±: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiol Scand 2005;49:222-31